• 21 September 2007

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

Read the article
  • 21 September 2007

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads

Read the article
  • 21 September 2007

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

Read the article
  • 21 September 2007

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

Read the article
  • 21 September 2007

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir

Read the article
  • 20 September 2007

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

Read the article
  • 20 September 2007

ICAAC: Sharp decline in HIV prevalence reported in pregnant women in rural northern Zimbabwe

Read the article
  • 20 September 2007

ICAAC: Dapivirine safe and tolerable as potential vaginal microbicide; displays potential in combination with other agents

Read the article
  • 20 September 2007

ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced

Read the article
  • 20 September 2007

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV

Read the article
  • 19 September 2007

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

Read the article
  • 19 September 2007

ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load

Read the article
  • 19 September 2007

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

Read the article
  • 19 September 2007

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

Read the article
  • 19 September 2007

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

Read the article
  • 19 September 2007

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

Read the article
  • 18 September 2007

ICAAC: Moxifloxacin could cut TB treatment time to four months

Read the article
  • 17 September 2007

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.